HPV- Human Papillomavirus

1133 Words3 Pages

Human Papillomavirus (HPV) is a sexually transmitted disease that has the potential for causing a variety of different diseases. HPV is sometimes a silent infection without any signs or symptoms. Consequently, HPV can be a deadly disease that can take lives through cancer or respiratory obstruction. HPV is a preventable disease with vaccination, or even by the body creating its own immunity. There are many different types of HPV that can cause infections, some of which are benign, while others promote cancer. Efforts are being made to decrease the incidence and prevalence of HPV worldwide.
Disease Characteristics of HPV
The causative agent is the HPV is a virus that consists of a double helix DNA strand virus that infects epithelial cells (CDC,). HPV is found in humans and is transmitted through sexual contact consisting of vaginal, anal, oral and genital-to-genital exposure. In very rare cases, a mother can expose her baby during labor and delivery (CDC). Portals of entry and exit are via the skin. Being asymptomatic and unaware of infection is very common with the different types of HPV. The period of communicability for HPV is unknown because there are many variations of the virus that results in different presentations, and there is a lack of signs and symptoms for many of these variations. Natural immunity can occur when exposure occurs and lies dormant while the immune system destroys the virus. The final complicating factor to communicability is there can be exposure and infection of multiple variations of HPV concurrently.
In cases where signs and symptoms are present, genital warts and abnormal Papanicolaou test (Pap test) are the most short-term complications. For women, the long-term complications include vulvar, vagi...

... middle of paper ...

...ce/pages/laryngeal.aspxDreyzehner, J. J. (n.d.). Tennessee emerging infections program. Retrieved from http://health.state.tn.us/ceds/EIP/Huh, W. K. (January 01, 2013). HPV vaccination in women treated for CIN2/3: it's still all about prevention. Gynecologic Oncology, 130, 2, 255-6.Cagney, H. (January 01, 2013). GAVI to fund HPV vaccines in low-income countries. The Lancet Oncology, 14, 3.)Maurer, F., & Smith, C. (2013). Community/public health nursing practice. (5 ed.). St Louis, Missouri: Elsevier Saunders.Human papillomavirus (hpv) and genital warts. (n.d.). Retrieved from http://www.niaid.nih.gov/topics/genitalwarts/Pages/default.aspxHuman papillomavirus (hpv) infection. (n.d.). Retrieved from http://www.cdc.gov/std/treatment/2010/hpv.htmHeymann, D. (2008). Control of communicable diseases manual. (19 ed.). Baltimore, MD: American Public Health Association.

More about HPV- Human Papillomavirus

Open Document